Active Ingredient History

  • Now
Dextropropoxyphene is an analgesic in the opioid category, patented in 1955 and manufactured by Eli Lilly and Company. It is an optical isomer of levopropoxyphene. It is intended to treat mild pain and also has antitussive and local anaesthetic effects. The drug has been taken off the market in Europe and the US due to concerns of fatal overdoses and heart arrhythmias. It is still available in Australia, albeit with restrictions after an application by its manufacturer to review its proposed banning. Its onset of analgesia is said to be 20–30 minutes and peak effects are seen about 1.5–2.0 hours after oral administration.   Wikipedia

More Chemistry
destropropossifene | destropropoxifene | dextropropoxifeno | dextropropoxiphene chloride | dextropropoxyphen | dextropropoxyphene | dextropropoxyphène | dextro propoxyphene hcl | dextropropoxyphene hydrochloride | dextropropoxyphene napsilate | dextropropoxyphene napsylate | dextropropoxyphenum | d-propoxyphene | d-propoxyphene napsylate


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue